CRWENewswire, Stocks to Watch. On its fourth quarter fiscal 2011, Synalloy Corp - SYNL - posted sales of $40,241,000, a 7% increase year over year, while its Net earnings for 2011 increased 44% to $5,797,000 or $0.91 per share compared to 2010. On its Metals Segment, Sales increased 9% to $29,974,000 while operating income increased 35% to $1,948,000 in the fourth quarter of 2011 from the same period a year earlier. Synalloy Corporation is structured as a holding company, currently comprised of two major groups: Metals and Chemicals./n***********************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

CLIPSHARE

Added by: karmastock
Tags: Nasdaq:SYNL Synalloy SYNL
Date: 2012-02-04

CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012. Threshold is also eligible to receive a $20 million milestone payment based on positive results from its randomized Phase 2 trial in pancreatic cancer. Total potential milestone payments are $525 million, comprised of $280 million in regulatory and development milestones and $245 million in sales-based milestones./n***********************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

CLIPSHARE

Added by: karmastock
Tags: merck Nasdaq:THLD THLD threshold
Date: 2012-02-04

Beat stress and anxiety is a web site that understands the pressures of everyday life and the challenges that we all face. It helps you face that challenge's of life with a scientifically proven audio download that will give you the strength and knowledge

CLIPSHARE

Added by: abegvideo1823
Tags: tension beat stress
Date: 2012-02-03

Beat stress and anxiety is a web site that understands the pressures of everyday life and the challenges that we all face. It helps you face that challenge's of life with a scientifically proven audio download that will give you the strength and knowledge

CLIPSHARE

Added by: abegvideo1823
Tags: tension beat stress
Date: 2012-02-02

Beat stress and anxiety is a web site that understands the pressures of everyday life and the challenges that we all face. It helps you face that challenge's of life with a scientifically proven audio download that will give you the strength and knowledge

CLIPSHARE

Added by: seovideo0710
Tags: tension beat stress
Date: 2012-02-02

Iteris Inc - ITI - reported financial results for its third quarter fiscal 2012, posting net sales and contract revenues of $14.9 million, a 24% increase compared to the same period the prior year. On its third quarter fiscal 2012, Cavco Industries Inc - CVCO - posted net sales of $114,564,000, a 189% increase year over year. Lime Energy Co. - LIME - reported award of a contract by NSTAR Electric ; Gas for the implementation of their Energy Efficiency Direct Install Program. Lime Energy will be one of several program providers, with territory exclusivity in Newton, Dedham, Needham and Westwood./n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: ITI CVCO LIME Nasdaq:LIME Amex:ITI Nasdaq:CVCO
Date: 2012-02-02

StemCells Inc - STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company’s proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration. On its first quarter fiscal 2012, Green Mountain Coffee Roasters Inc - GMCR - posted GAAP operating income of $145.8 million, compared to $23.3 million in the same period the prior year. Discovery Laboratories Inc - DSCO - reported that AFECTAIR is now registered with the FDA and is cleared to be marketed in the United States. AFECTAIR is a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support./n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: STEM GMCR DSCO Nasdaq:STEM Nasdaq:GMCR Nasdaq:DSCO
Date: 2012-02-02

Orion Marine Group Inc - ORN - reported a berth construction contract award of approximately $12 million for the Canaveral Port Authority in Florida. On its second quarter Fiscal Year 2012, CACI International Inc - CACI - posted record revenue of $973.2 million, a 12.2% increase year over year. Athersys Inc - ATHX - reported positive results from its Phase I clinical trial of MultiStem, its cell therapy product, administered to individuals undergoing allogeneic hematopoietic stem cell transplants for the treatment of leukemia and related conditions./n***************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://crwenewswire.com/disclaimer).

CLIPSHARE

Added by: karmastock
Tags: ORN CACI ATHX NYSE:CACI NYSE:ORN Nasdaq:ATHX
Date: 2012-02-01

On its Second Quarter Fiscal 2012, PAREXEL International Corp -PRXL - posted consolidated service revenue of $333.2 million, a 9.5% increase year over year. For the third quarter Fiscal 2012, PAREXEL expects to report consolidated service revenue in the range of $350 to $358 million. SMTC Corp - SMTX - reported the completion of a signed contract agreement to manufacture Alstom Transport’s leading edge transportation technology systems and products. Lannett Company Inc - LCI - reported that it has received approval from the FDA of its supplemental Abbreviated New Drug Application for Phentermine HCl Capsules, 15 mg. The company expects to commence shipping the product shortly. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity./n******/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: PRXL SMTX LCI Nasdaq:PRXL Nasdaq:SMTX Amex:LCI
Date: 2012-01-31

Verenium Corp - VRNM - reported an agreement with Tate ; Lyle for the use of one of its proprietary enzyme products in the development of novel food ingredients. Under the terms of the agreement, Verenium receives $1.5 million in near term milestone payments, revenues from enzyme product sales, and a royalty on Tate ; Lyle’s future sales. On its Fourth Quarter Fiscal 2011, Align Technology Inc -ALGN - posted record net revenues of $128.9 million, a 2.4% increase sequentially and 38.8% year-over-year. PanGeo Subsea Inc and Global Geophysical Services Inc - GGS - reported that they have entered into an agreement for the development and commercialization of the Acoustic Zoom product line./n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Diasclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: VRNM ALGN GGS Nasdaq:VRNM Nasdaq:ALGN NYSE:GGS
Date: 2012-01-31

On Track Innovations Ltd - OTIV - reported that it has been awarded a Contract to Supply Electronic Immigration Control System in Panama. The company expects to recognize revenues of approximately $6.9 million, with the potential for additional revenue in future years from follow-on contracts. ABB Ltd will acquire Thomas ; Betts Corp - TNB - for $72 per share in cash or approximately $3.9 billion. L ; L Energy Inc - LLEN - reported that it has entered an agreement acquiring 51% controlling interest of the Weishe coal mine in China/n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: OTIV TNB LLEN Nasdaq:OTIV NYSE:TNB Nasdaq:LLEN
Date: 2012-01-30

CRWENewswire, Stocks to Watch. GenVec Inc - GNVC - reported that it has extended its Research Collaboration and License Agreement with Novartis. Under the extension, Novartis will fund research at GenVec through January 2013 to support its hearing loss and balance disorders program. In January 2010, GenVec entered into a worldwide licensing and collaboration agreement with Novartis to discover and develop novel treatments for hearing loss and balance disorders. According to the company, under the terms of the agreement, if certain clinical, regulatory, and sales milestones are met, GenVec is eligible to receive up to $213.6 million, including upfront and milestone payments in addition to royalties on future sales. GenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines./n*********/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: Novartis GenVec GNVC NASDAQ:GNVC
Date: 2012-01-28

CRWENewswire, Stocks to Watch. Micronetics Inc - NOIZ - reported that it has been awarded a contract, valued at approximately $2.0 million, from a leading U.S. Department of Defense prime contractor. The contract is to design, develop, and deliver initial quantities of a key microwave subassembly. Micronetics manufactures microwave and radio frequency components and integrated subassemblies used in a variety of defense, aerospace and commercial applications. It also manufactures and designs test equipment and components that test the strength, durability and integrity of communication signals in communication equipment. Micronetics serves a diverse customer base, including BAE Systems, Boeing, General Dynamics, L-3 Communications, Lockheed Martin, Northrop Grumman and Raytheon/n******/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: Boeing Raytheon Micronetics Nasdaq:NOIZ NOIZ
Date: 2012-01-27

According to a definitive agreement, Eastman Chemical Company will acquire Solutia Incorporated - symbol SOA -. Solutia stockholders will receive $22.00 in cash and 0.12 shares of Eastman common stock for each share of Solutia common stock. On its first quarter fiscal 2012, Datawatch Corporation - symbol DWCH - posted total revenue of $6.27 million, a 50% increase year over year, and Net income of $603,000 compared to $229,000 in the same period the prior year. 1st Detect Corporation, a subsidiary of Astrotech Corporation - symbol ASTC - reported the delivery of pre-production mini-mass spectrometers to select customers for evaluation./n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: SOA DWCH ASTC NYSE:SOA Nasdaq:DWCH Nasdaq:ASTC
Date: 2012-01-27

On its second quarter fiscal 2012, Emulex Corp - ELX - posted net revenues of $128.7 million, an increase of 13% year-over-year and 9% sequentially. Wesco Aircraft Holdings Inc - WAIR - reported results for its first quarter fiscal 2012, posting record revenue of $192.6 million, an 11% increase compared to the same period the prior year. Charter Medical Ltd, a subsidiary of Lydall Inc - LDL -, reported that it received CE Mark approval on its next generation Cell Freeze Cryogenic Storage Containers for Hematopoietic Progenitor Cells/n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: ELX WAIR LDL NYSE:ELX NYSE:WAIR NYSE:LDL
Date: 2012-01-26

afghanz

CLIPSHARE

Added by: afghan
Tags: afghan
Date: 2012-01-26

nice video

CLIPSHARE

Added by: afghan
Tags: afghan
Date: 2012-01-26

RealNetworks Inc - RNWK - reported that it has signed an agreement to sell a significant number of its patents and its next generation video codec software to Intel Corporation for a purchase price of $120 million. According to a definitive merger agreement between the companies, Amgen will acquire Micromet Inc - MITI - for $11 per share in cash. Hemispherx Biopharma Inc - HEB - reported that the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, has approved the sale and distribution of Alferon N Injection (under the brand name “Naturaferon”) in Argentina/n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: RNWK MITI HEB Nasdaq:RNWK Nasdaq:MITI Amex:HEB
Date: 2012-01-26

On its fourth quarter fiscal 2011, United Rentals Inc - URI -, posted total revenues of $746 million compared with $597 million in the same period the prior year. Republic Airways Holdings Inc - RJET - has raised its guidance for year over year unit revenue increases on its Frontier Airlines branded operations for the Fourth Quarter of 2011. Navidea Biopharmaceuticals Inc - NAVB - reported that it has entered into an option agreement with Alseres Pharmaceuticals Incorporated to License Parkinson’s Disease Imaging Agent/n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: URI RJET NAVB NYSE:URI Nasdaq:RJET Amex:NAVB
Date: 2012-01-25

According to reports, Roche Holding AG has offered to buy Illumina Inc - ILMN - for $44.50 per share in cash, or for a total amount of about $5.7 billion. D. Medical Industries Ltd - DMED - reported that its subsidiary Spring Health Solutions Inc. has signed a non-exclusive agreement with Solara Medical Supplies Inc. for distribution of its Spring(TM) Universal Infusion Sets in the United States. McDermott International Inc - MDR - reported that its Australian subsidiary has received and signed a letter of award for the Ichthys Gas-condensate Field Development subsea umbilical, riser, flowline project by INPEX. According to McDermott, the contract value is in the order of magnitude of US$2 billion/n*********************************/nTHIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

CLIPSHARE

Added by: karmastock
Tags: ILMN DMED MDR Nasdaq:ILMN Nasdaq:DMED NYSE:MDR
Date: 2012-01-25